Pembrolizumab,MK-4830,Belzutifan,Lenvatinib,Quavonlimab,Favezelimab
Eisai,Merck
['gbm', 'rcc,(-irccs),(-srcc),(-urcc)', 'lenva', 'belzutifan']
thinking of belzutifan data in cns lesions for vhl not only is this now an option for these patients: it suggests potential for hif-2a targeting in cns tumors an rcc abstract showed promise for lenvatinib + belzutifan is this combo worth trying in gbm?
neuro-oncology 🧠 @ Emory — Working towards a better future for patients with CNS malignancies